1. |
ASHP guidelines for stress ulcer prophylaxis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1180,
1999,
Page 2-2
&NA;,
Preview
|
PDF (858KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
2. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1180,
1999,
Page 3-3
&NA;,
Preview
|
PDF (780KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
3. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1180,
1999,
Page 4-4
&NA;,
Preview
|
PDF (738KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
4. |
Counting the cost of Alzheimer's disease |
|
Inpharma Weekly,
Volume &NA;,
Issue 1180,
1999,
Page 5-6
Mark Greener,
Preview
|
PDF (1561KB)
|
|
摘要:
Few conditions are more devastating than Alzheimer's disease (AD), and it's a growing problem. A recent review of the burden of AD in the UK suggests that, by 2021, the number of cases will increase by 23-44% compared with 1996 levels.*Thus, as many as 663 100 people could have AD in the UK by 2021. US estimates paint an even bleaker picture, suggesting that between 7.5 million and 14.3 million people will have AD by 2050.1
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
5. |
Combined HBV/Hib vaccination for US infants cost effective? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1180,
1999,
Page 6-6
&NA;,
Preview
|
PDF (775KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
6. |
Effects of azelnidipine during exercise examined |
|
Inpharma Weekly,
Volume &NA;,
Issue 1180,
1999,
Page 7-7
&NA;,
Preview
|
PDF (735KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
7. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1180,
1999,
Page 8-8
&NA;,
Preview
|
PDF (754KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
8. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1180,
1999,
Page 9-9
&NA;,
Preview
|
PDF (770KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
9. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1180,
1999,
Page 10-10
&NA;,
Preview
|
PDF (780KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
10. |
Putting the squeeze on peripheral vascular disease |
|
Inpharma Weekly,
Volume &NA;,
Issue 1180,
1999,
Page 11-12
Nicola Ryan,
Preview
|
PDF (1623KB)
|
|
摘要:
Atherosclerotic narrowing or occlusion of vessels in the lower limbs results in peripheral vascular disease. Disease severity is related to the extent of vessel involvement and the available collateral circulation, and the most common manifestation of peripheral vascular disease is intermittent claudication. Leading investigators at the 48th Annual Scientific Session of the American College of Cardiology [New Orleans, US; March 1999] presented new results from several studies which aimed to treat intermittent claudication and other peripheral vascular disorders.
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|